Douglas G. Mashek

Douglas G. Mashek

Auto-generated profile, based on publicly available information

Douglas G. Mashek

University of Minnesota

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AGAndrew S. Greenberg
Andrew S. Greenberg
RCRosalind A. Coleman
Rosalind A. Coleman
Fredric B. KraemerFredric B. Kraemer
Fredric B. Kraemer
JMJames L. McManaman
James L. McManaman
MOMartin S. Obin
Martin S. Obin
DMDouglas G. Mashek
Douglas G. Mashek
Lipid droplets (LDs) are intracellular organelles that store neutral lipids within cells. Over the last two decades there has been a dramatic growth in our understanding of LD biology and, in parallel, our understanding of the role of LDs in health and disease. In its simplest form, the LD regulates the storage and hydrolysis of neutral lipids, including triacylglycerol and/or cholesterol esters. It is becoming increasingly evident that alterations in the regulation of LD physiology and metabolism influence the risk of developing metabolic diseases such as diabetes. In this review we provide an update on the role of LD-associated proteins and LDs in metabolic disease.

1 April 2017 in Cell Reports
Verified
Journal Article
Open access
ASAishwarya Sathyanarayan
Aishwarya Sathyanarayan
MMMara T. Mashek
Mara T. Mashek
DMDouglas G. Mashek
Douglas G. Mashek
Hepatic lipid droplet (LD) catabolism is thought to occur via cytosolic lipases such as adipose triglyceride lipase (ATGL) or through autophagy of LDs, a process known as lipophagy. We tested the potential interplay between these metabolic processes and its effects on hepatic lipid metabolism. We show that hepatic ATGL is both necessary and sufficient to induce both autophagy and lipophagy. Moreover, lipophagy is required for ATGL to promote LD catabolism and the subsequent oxidation of hydrolyzed fatty acids (FAs). Following previous work showing that ATGL promotes sirtuin 1 (SIRT1) activity, studies in liver-specific SIRT1-/- mice and in primary hepatocytes reveal that SIRT1 is required for ATGL-mediated induction of autophagy and lipophagy. Taken together, these studies show that ATGL-mediated signaling via SIRT1 promotes autophagy/lipophagy as a primary means to control hepatic LD catabolism and FA oxidation.

9 April 2020 in Obesity
Verified
Journal Article
Closed access
PDF file
Lisa S. ChowLisa S. Chow
Lisa S. Chow
EMEmily N. C. Manoogian
Emily N. C. Manoogian
AAAlison Alvear
Alison Alvear
JFJason G. Fleischer
Jason G. Fleischer
HTHonoree Thor
Honoree Thor
DMDouglas G. Mashek
Douglas G. Mashek

1 June 2011 in Chemical Reviews
Verified
Journal Article
Closed access
RCRosalind A. Coleman
Rosalind A. Coleman
DMDouglas G. Mashek
Douglas G. Mashek

24 September 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
KOKuok Teong Ong
Kuok Teong Ong
MMMara T. Mashek
Mara T. Mashek
SBSo Young Bu
So Young Bu
AGAndrew S. Greenberg
Andrew S. Greenberg
DMDouglas G. Mashek
Douglas G. Mashek
Despite advances in our understanding of the ways in which nutrient oversupply and triacylglycerol (TAG) anabolism contribute to hepatic steatosis, little is known about the lipases responsible for regulating hepatic TAG turnover. Recent studies have identified adipose triglyceride lipase (ATGL) as a major lipase in adipose tissue, although its role in the liver is largely unknown. Thus, we tested the contribution of ATGL to hepatic lipid metabolism and signaling. Adenovirus-mediated knockdown of hepatic ATGL resulted in steatosis in mice and decreased hydrolysis of TAG in primary hepatocyte cultures and in vitro assays. In addition to altering TAG hydrolysis, ATGL was shown to play a significant role in partitioning hydrolyzed fatty acids between metabolic pathways. Although ATGL gain and loss of function did not alter hepatic TAG secretion, fatty acid oxidation was increased by ATGL overexpression and decreased by ATGL knockdown. The effects on fatty acid oxidation coincided with decreased expression of peroxisome proliferator-activated receptor α (PPAR-α) and its target genes in mice with suppressed hepatic ATGL expression. However, PPAR-α agonism was unable to normalize the effects of ATGL knockdown on PPAR-α target gene expression, and this suggests that ATGL influences PPAR-α activity independently of ligand-induced activation. Conclusion: Taken together, these data show that ATGL is a major hepatic TAG lipase that plays an integral role in fatty acid partitioning and signaling to control energy metabolism. (Hepatology 2011)

1 August 2007 in Future Lipidology
Verified
Journal Article
Closed access
DMDouglas G Mashek
Douglas G Mashek
LLLei O Li
Lei O Li
RCRosalind A Coleman
Rosalind A Coleman
Thirteen homologous proteins comprise the long-chain acyl-CoA synthetase (ACSL), fatty acid transport protein (FATP), and bubblegum (ACSBG) subfamilies that activate long-chain and very-long-chain fatty acids to form acyl-CoAs. Gain- and loss-of-function studies show marked differences in the ability of these enzymes to channel fatty acids into different pathways of complex lipid synthesis. Further, the ability of the ACSLs and FATPs to enhance cellular FA uptake does not always require these proteins to be present on the plasma membrane; instead, FA uptake can be increased by enhancing its conversion to acyl-CoA and its metabolism in downstream pathways. Since altered fatty acid metabolism is a hallmark of numerous metabolic diseases and pathological conditions, the ACSL, FATP and ACSBG isoforms are likely to play important roles in disease etiology.